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Background: CMR is considered the ‘gold standard’ for non-invasive LV and RV mass quantitation. This information is
solely based on gradient-recalled echo (GRE) sequences while contrast dependent on intrinsic T1/T2 characteristics
potentially offers superior image contrast between blood and myocardium. This study aims, for the first time in
humans, to validate the SSFP approach using explanted hearts obtained from heart transplant recipients. Our objective
is establish the correlation between and to validate steady-state free precession (SSFP) derived LV and RV mass vs.
autopsy mass of hearts from cardiac transplants patients.
Methods: Over three-years, 58 explanted cardiomyopathy hearts were obtained immediately upon orthotopic heart
transplantation from the OR. They were quickly cleaned, prepared and suspended in a saline-filled container and
scanned ex vivo via SSFP-SA slices to define LV/RV mass. Using an automatic thresholding program, segmentation was
achieved in combination with manual trimming (ATMT) of extraneous tissue incorporating 3D cardiac modeling
performed by independent and blinded readers. The explanted hearts were then dissected with the ventricles
surgically separated at the interventricular septum. Weights of the total heart not excluding papillary and trabecular
myocardium, LV and RV were measured via high-fidelity scale. Linear regression and Bland-Altman plots were used to
analyze the data. The intra-class correlation coefficient was used to assess intra-observer reliability.
Results: Of the total of 58 explanted hearts, 3 (6%) were excluded due to poor image quality leaving 55 patients (94%)
for the final analysis. Significant positive correlations were found between total 3D CMR mass (450 ± 111 g) and total
pathology mass (445 ± 116 g; r = 0.99, p < 0.001) as well as 3D CMR measured LV mass (301 ± 93 g) and the pathology
measured LV mass (313 ± 96 g; r = 0.95, p < 0.001). Strong positive correlations were demonstrated between the 3D CMR
measured RV mass (149 ± 46 g) and the pathology measured RV mass (128 ± 40 g; r = 0.76, p < 0.001). The mean bias
between 3D-CMR and pathology measures for total mass, LV mass and RV mass were: 3.0 g, -16 g and 19 g, respectively.
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Conclusions: SSFP-CMR accurately determines total myocardial, LV and RV mass as compared to pathology weighed
explanted hearts despite variable surgical removal of instrumentation (left and right ventricular assist devices, AICD and
often apical core removals). Thus, this becomes the first-ever human CMR confirmation for SSFP now validating the
distinction of ‘gold standard’.
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An accurate and reproducible measurement of both left
ventricular mass (LVM) and right ventricular mass (RVM)
is important for cardiac risk stratification. Currently, cardio-
vascular magnetic resonance (CMR) imaging is considered
the ‘gold standard’ for non-invasive measurement of left
and right ventricular volume, mass and by extension LVEF
and RVEF [1,2]. CMR offers a spatially defined 3D data set
that spans the entire heart. The volume and mass measure-
ments afforded by CMR are thus independent of cardiac
geometric assumptions and are a major advantage over 1D
and 2D echocardiography. This issue is particularly im-
portant for the RV, as its complex, crescentic geometry
is challenging for mathematical modeling, placing
increased importance on accurate mass calculations
free of geometric assumptions [3]. A variety of prior
studies have demonstrated CMR’s superior accuracy
and reproducibility in assessing ventricular volumes
over other imaging modalities, including M-mode and
2D echocardiography [4-9]. While the assessment of
left ventricular mass by real-time 3D echocardiography
has overcome some of the geometric assumptions re-
quired of 2D echocardiography methods, its clinical
utility is still limited when characterizing the right ven-
tricle and in patients with a poor acoustic window [10].
An ideal way to assess the mass calculation capabilities
and intrinsic accuracy of any imaging modality is to
independently compare the imaging-derived mass to a
corresponding autopsy mass. In this way Devereux and
Reichek in 1977 performed their seminal work compar-
ing echocardiography with autopsy validation to derive
an imaging-based left ventricular mass equation [11].
Their approach is closely replicated herein for the first
time with CMR. Briefly, their intrepid work involved
identifying terminally ill patients and obtaining research
echocardiograms prior to autopsy, then comparing these
in vivo ventricular mass measurements to the autopsy
measurements. Before then, the determination of echo-
cardiographic LV mass calculations was only postulated,
not validated by autopsy. Currently, the recognition of
CMR as the gold standard for non-invasive left and right
ventricular mass calculation is largely based on animal
and phantom data; the only human autopsy studies, as
explained below, do not utilize the most recent pulsesequences, undermining the credibility of CMR as the
true ‘gold standard’ [12-15]. Moreover, these older stud-
ies, in addition to small sample sizes, employed spin-
echo or gradient recalled echo (GRE) pulse sequences
for image acquisition. GRE sequences had numerous
well defined deficiencies including flow-related enhance-
ment and reliance on flow to define cardiac boundaries
with consequent overestimation of mass and underesti-
mation of volume. Despite these limitations, GRE served
remarkably well for several decades. However, as is well
known, the newer steady-state free precession (SSFP) ap-
proach not only has become the workhorse sequence for
CMR due to its intrinsic T1/T2 contrast attributes but
has become the de facto gold standard for measurement
of LV mass due to its inherent resolution. Thus, there is
an obligate need to reassess and validate CMR using
SSFP sequences as the current gold standard for ven-
tricular mass quantification.
It should be noted that when validated with animal
data, SSFP was shown to be the scanning sequence that
yielded CMR-derived ventricular mass closest to the aut-
opsy mass [16]. Thus, the next logical step is to validate
mass acquisition by CMR’s SSFP sequences in human
hearts by autopsy. Therefore, the aim of our study was
to establish a correlation between CMR derived left and
right ventricular mass and autopsy-derived ventricular
mass of ex vivo hearts from heart transplants using the
SSFP sequence, thereby determining the credibility of
CMR as the gold standard for non-invasive left and right
ventricular mass calculation. However, today’s ability to
replicate the autopsy approach used by Devereux and
Reichek is more constrained than in the past as the
more restrictive research environment, with increased
protection of patients and institutional review boards,
makes it all but impossible to duplicate their methods.
Nonetheless, there are alternative ways, which are more
sensitive to patients’ rights and would achieve similar
results to what was done in the 1970’s, to execute this
study. Our solution was to use the diseased hearts
(explanted) from orthotopic heart transplantation as the
source of hearts for imaging. Naturally, this approach
removes the need and arguable issue of in vivo scanning
of terminally ill patients just to establish a bona fide gold
standard.
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In this prospective IRB approved study, explanted hearts
from heart transplant recipients (n = 58) were obtained
at the time of orthotopic transplantation within five mi-
nutes of harvest. The hearts were prepared by trimming
atria and vascular components leaving only LV and RV
myocardium including papillary and trabecular tissue.
The hearts were submerged in a saline filled plastic con-
tainer and CMR imaging was performed (GE, Milwaukee,
WI; 1.5 T) using standard steady-state-free-precession
(SSFP) approach (TR/TE/flip angle 4.2/2.1/45; FOV
350 mm, matrix 256 × 256, scan percentage 100%.)
with slices oriented parallel to the LV short axis,
applied contiguously from base to apex (slice thickness
8 mm, gap 0 mm). A birdcage design neurovascular
coil was used to receive the signal. Using an image ana-
lysis program available with our scanner (Medis, The
Netherlands), Automatic Thresholding with Manual
Trimming (ATMT) was performed on the CMR set of
images to isolate and contour cardiac tissue. Specific-
ally, the ATMT approach was utilized given the com-
plexity of the heart analysis with necessary removal of
LVAD and/or RVAD apical cores, lateral wall surgical
frozen section removal and AICD/PM lead extractions that
markedly and exceptionally non-uniformly destroyed the
primary myocardial architecture and geometry so critical
for natural and heuristic manual endocardial and epicardial
contour analysis. Formally, ATMT involved the automatic
setting of an upper and lower myocardial signal threshold
such that cardiac tissue was, via signal intensity, isolated
from the surrounding saline bath signal from which the
heart was suspended for imaging. Secondly, the signal was
rendered as a 3D structure, which could be rotated within
the viewing station permitting more user-controlled defined
ROI contours to the often no-longer intuitive LV/RV
geometry. Using a succession of cuts applied to the 3D
model, non-cardiac tissue signal (saline which had near
identical signal intensity to fat, distortion artifacts as
apex approached the container and retained air) was
systematically removed leaving a 3D model for the in-
dependent and blinded reader facilitating final manual
contouring. In short: assisted manual contouring to
permit formal comparison of CMR mass to autopsy
mass whereas the former is and the latter is not
dependent on uniformity of structure (Figure 1).
Initially, the whole cardiac structure was isolated, and
using the features of the processing software, the volume
of myocardium was determined. Next, this was con-
verted into grams by multiplication of the density of
myocardium, taken as 1.055 g/mm3. After recording the
total cardiac volume, the same model was further oper-
ated on to remove the RV structure by use of a series of
digital ‘cuts’ applied to the 3D model. The remaining
tissue (typically trimmed to a semi elliptical structure)was measured and taken as the LV or RV volume. Follow-
ing performance of the CMR examination, the explanted
hearts were returned to the Pathology Lab, where the whole
heart was weighed using a high-fidelity scale. The patholo-
gist then formally separated the RV tissue using scissors,
and the RV and LV tissue were weighed separately. These
steps understandably required intricate coordination be-
tween the transplant surgeons, pathologists and the CMR
Laboratory day or night given the natural nuances of
obtaining donor hearts. Finally, ten random explant hearts
were also reanalyzed to establish the intra-observer variabil-
ity by the same observer (GR) using the exact same tech-
nique. The reanalysis was blinded and took place 4 months
after the initial analysis to avoid memory bias.
Statistical analysis
Continuous variables were expressed as mean + standard
deviation and compared using the independent samples t
test. Categorical variables were expressed as counts and
percentages. Linear regressions were performed to assess
the correlation of cardiac mass weights between the SSFP-
CMR method and ex-vivo heart autopsy method. Bland-
Altman plots were used to determine the bias and 95%
limits of agreement between methods. A two-tailed p-value
<0.05 was considered to indicate statistical significance. The
intra-class correlation coefficient (ICC) was calculated to
assess intra-observer reliability between measures of 3D
MRI volumes made by a single rater using the ATMT
method. The ICC model used was two-way mixed and the
type was absolute agreement. The values of ICC range be-
tween 0 and 1.0, with values closer to 1.0 representing
stronger reliability. Portney and Watkins [17] suggested
that ICC value above 0.75 indicate good reliability, those
between 0.5 and 0.75 indicate moderate reliability, and
those below .50 indicate poor reliability). Data was analyzed
using IBM SPSS Statistics, version 20.0 (IBM Corporation,
Armonk, NY).
Results
A total of 58 explanted hearts were imaged; 3 (5%) were
excluded due to poor image quality (peri-surgical destruc-
tion) leaving 55 (95%) for the final analysis. Of the 55
explanted hearts, 39 (71%) were men, and 16 (29%) were
women (mean age 55 ± 11 years, range 23 to 73 years). A
significant proportion of the explanted hearts belonged to
ischemic (47%) and non-ischemic heart disease (36%) pa-
tients (Table 1). Instrumentation was present in all but two
patients comprised of AICD and or PM (93%), LVAD
(60%), RVAD (15%) and/or RVAD/LVAD (12%). All (100%)
patients had LV and RV (42%) myocardial surgical resection
of varying amounts averaging 3x3cm. The average time
from Transplant Suite to Pathology Department was
25 ± 5 and from Pathology to CMR notification was
30 ± 5 minutes. CMR preparation time (RB or RW) was
Figure 1 Summary of ATMT steps. a) Cross-sectional view of an explanted heart submerged in a cylindrical water bath. c) Application of
upper and lower intensity thresholds to eliminate bulk of signal associated with the water bath. c) By successively removing extra-cardiac
features, the 3D heart voxels are isolated. d) To isolate the left ventricle an irregular region encompassing the right ventricle is manually
identified for removal.
Table 1 Heart transplant demographics
Demographics Number (55)
Age (years) 55 ± 11
Female 16 (29%)
Male 39 (71%)
Ischemic Cardiomyopathy 26 (47%)
Hypertrophic Cardiomyopathy 2 (4%)
Miscellaneous Etiologies 3 (6%)
Non-ischemic Cardiomyopathy 20 (36%)
Re-transplantation 4 (7%)
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formaldehyde preservation. The processing time per
image series was approximately 8–10 min; not signifi-
cantly different than standard manual contouring. The
total time the hearts were rerouted to the CMR facility
was < 60 minutes.
Extremely strong positive correlations between total
CMR 3D mass (450 ± 111 g) and total pathology mass
(445 ± 116 g; r = 0.99, p < 0.001) and the 3D CMR mea-
sured LV mass (301 ± 93 g) versus the pathology mea-
sured LV mass (313 ± 96 g; r =0.95, p < 0.001). Strong
positive correlation was demonstrated between the 3D
CMR measured RV mass (149 ± 46 g) and the pathology
measured RV mass (128 ± 40 g; r = 0.77, p < 0.001) R = 0.77
(Table 2). The equations y = 1.023 ×– 15.2b (r = 0.99); y =







CMR mass (g) 450 ± 111 301 ± 93 149 ± 46
Pathology
mass (g)
445 ± 116 313 ± 96 128 ± 40
R Value 0.99 0.95 0.77
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regressed the total mass, LV mass and RV mass respectively
(Figure 2). The average bias between 3D CMR and path-
ology measures for total mass, LV mass and RV mass were:
3.0 g (95% limits of agreement (LOA) -39 to 46), -16 (-82
to 50), and 19 g (-41 to 80), respectively. The differences
between CMR measured mass and pathology mass for
all three indices were illustrated in Bland-Altman plots
(Figure 3).
The intraclass correlation coefficient (ICC) was calcu-
lated for ten randomly selected hearts (15%) to assess
intra-observer reliability between measures of 3D MRI
volumes made by a single rater using the ATMT
method. For 3D MRI total volume measured in OctoberFigure 2 Linear Regression Analysis CMR vs. Pathology Mass. a: compariso
by cardiac magnetic resonance imaging with autopsy/pathology mass. b: Li
measurement by cardiac magnetic resonance imaging with autopsy/pathol
(RV) mass measured by cardiac magnetic resonance imaging with autopsy/p2013 versus the February 2014 measurement was 0.990
(95% confidence interval, 0.958 to 0.998). For 3D MRI
LV volume the ICC measurement was 0.986 (95% confi-
dence interval, 0.948–0.997). For 3D MRI RV volume
the ICC measurement was 0.730 (95% confidence inter-
val, 0.234–0.925).
Discussion
The ideal method for quantification of ventricular mass
should be fairly quick, non-invasive, highly accurate and
reproducible and applicable to each ventricle. In our
study, we were able demonstrate that total ventricular
mass, LV and RV mass obtained by CMR showed excel-
lent correlation with histopathology mass obtained on
the explanted hearts (r = 0.99, 0.95, and 0.77, respect-
ively). This study demonstrates that accurate and repro-
ducible assessment of both left and right ventricular
masses can be efficiently obtained non-invasively using
CMR’s SSFP sequences, as compared to weighed, explanted
human donor hearts. Most importantly, this is the final
validation step so critical in unequivocally depicting CMR
as the true ‘gold standard’ that heretofore had beenn of combined ventricular, left and right ventricular mass measurement
near regression analysis: comparison of left ventricular (LV) mass
ogy mass. c: Linear regression analysis: comparison of right ventricular
athology mass.
Farber et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:74 Page 6 of 9
http://jcmr-online.com/content/16/1/74remarkably accepted de facto given the distinct and glaring
absence of such a validation step.
Considered not possible in the current era, a confirm-
ation similar to the manner in which Devereux and Reichek
first validated echocardiographic mass (Penn Equation)
required a resourceful contemporary approach. Awaiting a
person’s imminent death is considered taboo by stateside
IRB’s and justifiably so. Arriving on a natural ready supply
of explanted ex vivo hearts, while not in vivo, was the
crucial element and an aspect that fundamentally required
an exceptional synchronization amongst the Cardiac
Transplant Service, Pathology and CMR Laboratory at
any time. These invaluable results were obtained des-
pite several possibly obfuscating variables. Chiefly, the
cardiomyopathic, ex-planted hearts all possessed variable
mechanical instrumentation before transplant, including
left and right ventricular assist devices (LVAD/RVAD) and
implantable cardioverter-defibrillators (AICD) and/or pace-
makers. The removal of this instrumentation upon explan-
ation often led to partial or full apical core removal, leaving
an apical interface that was far more difficult to assess when
drawing epicardial and endocardial contours (Figure 4). As
well, a separate lateral wall surgical section was always re-
moved for Surgical Pathology for confirmation of etiology
of the cardiomyopathy. Thus, there was a substantial inher-
ent destruction and radical distortion of the primary vari-
able, potentially leading to wholesale inability to achieve
reliable correlation. The fact that the whole heart, left and
right ventricular masses still correlated extremely well with
the weighed masses is a further testament to the accuracy
of CMR; an even higher correlation is predicted when the
natural boundaries of the heart, with the apex fully intact,
provide an enhanced guide for contouring as in routine
CMR imaging. A final factor to consider is the use of a
cardiomyopathic patient population in this study. Ideally,
a separate subgroup of non-cardiomyopathic hearts to
establish a second correlation between CMR-derived and
weighed ventricular LV and RV mass would be ideal. How-
ever, the use of less diseased, non- cardiomyopathic hearts
would prove less problematic for epicardial and endocardial
contouring, which would likely improve the accuracy of the
CMR mass quantitation.
Establishing the accuracy and reproducibility of CMR
measured cardiac mass has important implications for
clinical practice and research. Prognostic significance of
left ventricular mass regression was demonstrated by
showing fewer rates of clinical end points in patients
with lower LV mass during antihypertensive treatment
[18]. An increase in left ventricular mass predicts a
higher incidence of cardiovascular events including
death and this information is in addition to that pro-
vided by the evaluation of traditional cardiovascular risk
factors [19]. Thus, accurate measurement of LV mass by
CMR has important clinical implications in terms of riskassessment and regression of LV mass in response to
treatment. Interestingly, there are no studies in the lit-
erature that directly compared RV mass with prognosis.
Our study further adds to the literature in demonstrat-
ing strong correlation between CMR measured RV mass
and pathology mass. We believe this study provides a
steppingstone for the use of RV mass as a prognostic
stool as well as for assessing response to treatment in
patients with pulmonary hypertension.
In a landmark paper, Bottini et al. demonstrated that
detecting a 10 gram regression in LV mass with a power
of 0.8 and p < 0.05 would require 550 patients using
echocardiography but only require 17 patients using
CMR. Thus, much smaller sample sizes can be used to
detect the same change in LV mass, or smaller degrees
of changes can be identified using the same sample size.
Moreover, the precise measurement of ventricular mass
has been proposed to more easily be utilized in a thera-
peutic approach, such as in LV mass regression with antihy-
pertensive therapy [20]. The implications are important in
that therapeutic efficacy, risk stratification and general ac-
curacy can only be obtained when an exacting method is
available. In this study, linear regression analysis indicated
excellent correlations as shown in Figure 2 for all three
indices including total cardiac mass, LV mass and RV mass
determined by using 3D CMR with ATMT technique and
true LV mass obtained at autopsy on explanted hearts. The
differences between CMR measured mass and pathology
mass including systemic and random differences for all
three indices were illustrated in the Bland-Altman plots
(Figure 3). The bias between CMR measured mass and
pathology mass were low and not systematic.
An important and controversial consequence of this
work has emerged. Namely does the conventional long
accepted dogma for cardiac mass quantification exclud-
ing certain mass (papillary and trabecular mass) need to
be discarded? It is well known that papillary muscles
have the same thickness as the left ventricular free wall.
Additionally, in patients with LV hypertrophy there is a
proportional hypertrophy of the papillary muscles [21].
In a study by Francois, et al [14] it was demonstrated
that the most accurate estimates of the LV mass in ani-
mal models were obtained when the papillary muscles
were included in the myocardium. Furthermore, when
the papillary muscles were excluded from the LV mass,
the values were significantly lower than pathology mass
measured at autopsy. However, historically, it is interest-
ing to note that in the initial validation of GRE the
correlations were improved by excluding the papillary
muscles and fine trabecular tissue, no doubt due to the
well-known flow-related enhancement that occurred
with GRE causing overestimation, not underestimation.
This then triggered the venerable mathematical regres-
sion correction we now use today. Interestingly, despite
Figure 3 Bland-Altaman plots. a) Combined ventricular mass by CMR vs. pathology mass. b) LV mass by MRI vs. pathology mass, and c) RV
mass by MRI vs. pathology mass.
Figure 4 Long axis view of suspended explanted heart featuring
destruction of the anterior wall and missing apex due to previous
LVAD instrumentation.
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sequences, devoid of this artifact, has not sparked a plea
for reconsideration of the general approach of excluding
papillary and trabecular tissue. Similar to the previous
SSFP animal studies, our study incorporated papillary
muscles and trabecular mass by using the ATMT method
in calculating total LV mass while obtaining near unity
with true autopsy mass. Further, the new regression equa-
tion now includes, not excludes, papillary and trabecular
mass suggesting that our Society should now incorporate
both into our manual contouring approaches. In conclu-
sion, to our knowledge this study represents the first hu-
man modern CMR versus autopsy validation of human
ventricular mass, and fairly emulates the intrepid days of
the initial validation of the Penn Formula by Devereux
and Reichek in 1977.
Study limitations
Our chief limitation is that CMR scans were performed
on ex-vivo hearts that were suspended in normal saline
and these specimens obligatorily do not suffer from
temporal resolution issues encountered in in-vivo, live,
beating hearts. The contribution of this temporal blur is
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mation encountered by systematically excluding import-
ant myocardium. It should also be noted that the initial
premise of our study was to image patients referred for
heart transplant via CMR, but as our center is a large
tertiary/quaternary referral base, only the rare patient
presented without an AICD. None of the hearts in our
study had normal pathology and, in addition, significant
numbers of explanted hearts (98%) possessed variable
mechanical instrumentation before transplantation (e.g.
LVADs, RVADs, and AICDs) which confounded natural
contouring. The removal of this instrumentation upon
explanation often led to partial or full apical (often
biventricular) core removal, leaving an apical interface
that was more difficult to assess when drawing epicardial
and endocardial contours. Yet, despite the high preva-
lence of patients with prior mechanical instrumentation
and the attendant difficulties of imaging these hearts, we
still found excellent correlations between CMR and aut-
opsy myocardial mass which supports the value of our
approach. Further, that the RV correlations were less
than the LV correlations might be expected due to the
disproportionate effect of loss of RV contours with surgi-
cal manipulation. Less expected however was the effect
in which the now deflated heart post-explant lost its RV/
septal margins making separation of RV and LV less pre-
cise. In that the whole heart demonstrates near identity
with autopsy weight prior to separation attests to the
fidelity of the approach mitigating the absolute process
itself. Finally, explanted hearts in this study were imaged at
higher resolution than in-vivo hearts. For the purpose of
the study, a limited separate analysis showed no significant
difference when measured at conventional resolution.
Conclusions
SSFP-CMR accurately determines total myocardial, LV and
RV masses as compared to weighed explanted hearts, des-
pite variable surgical removal of instrumentation (LVAD/
RVAD, AICD’s and often apical core removals) in a trans-
plant population. Thus, while GRE was the original ‘gold
standard’ for LV mass, SSFP, despite its current universal
acceptance as the ‘de facto’ gold standard’, is now formally
validated in this autopsy study. Further, the regression
equation now includes, not excludes, papillary and tra-
becular mass supporting the notion that our Society
should consider incorporating both into standard cardiac
measurements.
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